​RGA Announces Strategic Relationship with Synodex

ST. LOUIS, February 18, 2014 – RGA Reinsurance Company announced today it has agreed to a strategic relationship with Synodex, which will include use of Synodex APS.Extract™ data and incorporate other Synodex data into its product offerings.

APS.Extract™ is a computer-addressable electronic data feed and customizable report produced from healthcare records by Synodex, a division of Innodata Inc. (NASDAQ: INOD). It is used by insurance carriers and reinsurers in connection with life insurance risk assessment and claim investigation.
 
“RGA began testing and validating the Synodex APS.Extract process and product with several client evaluations starting in late 2011,” said Dave Wheeler, Senior Vice President, U.S. Underwriting, RGA Reinsurance Company. “Based on these tests and validations, we have become confident in Synodex’s ability to deliver high-quality, consistent data that accurately depicts even the most complex medical cases, and we have confidence in this tool as a key component in the underwriting process. We anticipate that our clients who use Synodex should be able to place more business with improved efficiency while at the same time enhancing the quality of their underwriting decisions as part of their qualifying underwriting processes.

“In addition, we have begun implementing innovative product enhancements using Synodex APS.Extract data. By incorporating Synodex data into RGA’s Rx automated scoring system, we will not only be able to assign risk or severity scores to drug prescriptions fulfilled, which we do today, but will also be able to  assign scores to drug prescriptions issued, which we see as providing further protective value.   Additionally, we have begun designing innovative underwriting programs whereby we automatically assign risk scores – much like we do with Rx today – based on an entire medical history using Synodex data. We are enthusiastic about the prospect that Synodex’s innovation holds for the industry,” Wheeler concluded.